drugset / Trial / NCT05137080

Dexamethasone and Functional Outcome After TKA

NCT05137080 ↗

Phase 4 Completed 162 enrolled Slagelse Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients previously included in the DEX-2-TKA-trial (ethics committee ID SJ-695; ClinicalTrials.gov: NCT03506789) at Næstved Hospital will be invited for a follow up study consisting of questionnaires and a visit with a physical therapist. The study includes the following validated questionnaires: EQ-5D-5L, Oxford Knee Score and PainDetect, and information on height, weight, daily pain-medication and co-morbidities. With the physical therapist, the patient will perform the following functional tests: knee range of motion, timed-up-to-go, 30 second chair stand test, 40m fast paced walk test, stair climb test and a measure of the thigh force.

Timeline

Start
2021-12-15
Primary completion
2022-06-07
Completion
2022-06-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 24 mg Intravenous

Indications